(Q49106466)

English

LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

cerebral infarction

1 reference

based on heuristic

inferred from title

author name string

O'Neill MJ

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Hicks CA

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Ward MA

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Osborne DJ

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Wishart G

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Mathews KS

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

McLaughlin DP

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Stamford JA

8

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

McCarty DR

9

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Patrick KE

10

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Roman C

11

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Fleisch JH

12

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Gilmore J

13

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Boot JR

14

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

888

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

138-149

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Drugs acting on calcium channels: potential treatment for ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

P/Q-type Ca2+ channel blocker omega-agatoxin IVA protects against brain injury after focal ischemia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Pharmacological profile of a novel neuronal calcium channel blocker includes reduced cerebral damage and neurological deficits in rat focal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Excitotoxic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Failure of levemopamil to improve histological outcome following temporary occlusion of the middle cerebral artery in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

(S)-emopamil protects against global ischemic brain injury in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Exploration of P-type Ca2+ channels as drug targets for the treatment of epilepsy or ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Postischemic (S)-emopamil therapy ameliorates focal ischemic brain injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

(S)-emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Caspases: killer proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Neuronal protective effects of calcium antagonists in cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Identification of calcium channels involved in neuronal injury in rat hippocampal slices subjected to oxygen and glucose deprivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Involvement of N- and P/Q- but not L- or T-type voltage-gated calcium channels in ischaemia-induced striatal dopamine release in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Caspases and caspase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

The effects of SB 206284A, a novel neuronal calcium-channel antagonist, in models of cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Reversible middle cerebral artery occlusion without craniectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

The omega-conopeptide SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903043-2

7 January 2021

Identifiers

10.1016/S0006-8993(00)03043-2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/11146060

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49106466&oldid=1372478271"